Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-23-032932
Filing Date
2023-09-18
Accepted
2023-09-18 16:53:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 defa14a.htm DEFA14A 14919
2 defa14a_001.jpg GRAPHIC 635420
3 defa14a_002.jpg GRAPHIC 522397
  Complete submission text file 0001493152-23-032932.txt   1610848
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38286 | Film No.: 231261708
SIC: 2834 Pharmaceutical Preparations